Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
Sign Up to like & getrecommendations! Published in 2021 at "PLoS Medicine"
DOI: 10.1371/journal.pmed.1003813
Abstract: Background We investigated safety, tolerability, and immunogenicity of the heterologous 2-dose Ebola vaccination regimen in healthy and HIV-infected adults with different intervals between Ebola vaccinations. Methods and findings In this randomised, observer-blind, placebo-controlled Phase II… read more here.
Keywords: vaccination; ad26 zebov; mva filo; hiv infected ... See more keywords
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "PLoS Medicine"
DOI: 10.1371/journal.pmed.1003865
Abstract: Background Reoccurring Ebola outbreaks in West and Central Africa have led to serious illness and death in thousands of adults and children. The objective of this study was to assess safety, tolerability, and immunogenicity of… read more here.
Keywords: safety; ad26 zebov; vaccination; mva filo ... See more keywords